Fresenius Medical Care AG (FMS) Cash from Investing Activities (2009 - 2026)

Fresenius Medical Care AG's Cash from Investing Activities history runs 18 years deep, the most recent figure standing at -$198.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 74.27% year-over-year to -$198.4 million; the TTM figure through Mar 2026 stood at $256.3 million (down 66.0% YoY), while the FY2025 annual figure was $2.3 billion, down 7.31% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$198.4 million, down from $678.6 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $761.9 million in Q4 2024, with the low at -$241.5 million in Q3 2024.
• The 5-year median for Cash from Investing Activities is -$113.9 million (2025), against an average of $56.1 million.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities jumped 339.22% in 2024, then plunged 146.29% in 2025.
• Fresenius Medical Care AG's Cash from Investing Activities stood at $382.6 million in 2022, then surged by 75.2% to $670.3 million in 2023, then climbed by 13.67% to $761.9 million in 2024, then retreated by 10.93% to $678.6 million in 2025, then sank by 129.24% to -$198.4 million in 2026.
• Business Quant data shows FMS's Cash from Investing Activities at -$198.4 million in Q1 2026, $678.6 million in Q4 2025, and -$63.1 million in Q3 2025.